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62a Sunday, February 26, 2012electron donating properties that would optimize photoinduced electron trans-
fer (PET) from the ligand to the protein and prompt charge-induced conforma-
tional changes.
Our study focuses on the interaction of four 3,9-substituted perylenes with Hu-
man Serum Albumin (HSA), which is the prime protein model for the binding
of PAH. We present docking simulation results for possible sites for the pery-
lenes within HSAwith the lowest free energy of binding and correlate the dock-
ing simulations with fluorescence result. Docking simulations reveal that all the
peylen derivatives bind at the core of HSA and that the dimethoxy derivative
has larger affinity than the other perylenes. Docking seems to be stabilized
by aromatic interactions with Tyr and Trp groups.
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Calmodulin (CaM) is a calcium-binding protein that mediates signal transduc-
tion through an ability to differentially bind to highly variable binding
sequences in target proteins. Experimental measurements show a linear corre-
lation between conformational entropy and overall binding entropy, suggesting
that a predictive ability to calculate conformational entropy is critical to the
identification of binding partners and their relative affinities. To identify
how binding affects low- and high-frequency motions, and their relationships
to conformational entropy, we have employed fully atomistic molecular dy-
namics simulations with explicit solvent. The calculated quasiharmonic entro-
pies of CaM bound to the targets relative to unbound CaM are in agreement
with experimentally derived conformational entropies, where extrapolation
to infinite simulation time showed that at least 92% of the backbone entropy
is captured over the course of the 100 ns simulation. Enhanced side chain en-
tropy results from conformational disruption of the protein backbone within
loop regions between sub-domain elements, acting to facilitate the formation
of transient salt bridges between Lys148 at the C-terminus and GLU sidechains
both in CaM helix A and GLU side-chains present in selected binding se-
quences (i.e., endothelial and neuronal nitric oxide synthases). Comparison
of Ca root-mean-squared fluctuations and MET sidechain dihedral distribu-
tions of CaM bound to each of the targets revealed that MET sidechains
have more torsional freedom when the backbone is more flexible, showing
that MET sidechain rotation mirrors the overall conformational binding en-
tropy. Taken together, these results help to illuminate the interplay between
electrostatic, hydrophobic, backbone and sidechain properties in the ability
of CaM to recognize and discriminate against targets by tuning its conforma-
tional entropy.
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Lactate Dehydrogenase (LDH) catalyzes the interconversion of pyruvate and
lactate with concomitant interconversion of NADH and NADþ. Due to the
widespread presence in a variety of organisms, LDH has been served as a gen-
eral model for studying the catalytic mechanism of enzymes. Extensive IR
spectroscopic studies by Callender et al. have revealed complex conformational
sub-states for different substrate binding to LDH in mesophilic and thermo-
philic organisms. To facilitate the elucidation of the underling mechanism of
LDH enzyme reaction, molecular dynamics simulation approaches were ap-
plied to study the conformational dynamics of mesophilic LDH in complex
with substrate or its mimics. The functionally important motions were charac-
terized by conformational sampling. To determine the relationship between
protein stability, flexibility, and catalytic activity, thermophilic LDH enzyme
will be further investigated. The energy landscape within the Michaelis com-
plex will be explored. The computational study in connection with the experi-
mental findings will shed new light on the mechanism of enzyme dynamics and
function.
315-Pos Board B101
Understanding Allosteric Inhibition in Ligand AG6 Bound to NS5B using
Molecular Dynamic Simulations
Tijesunimi J. Odebode.
University of Maryland, Baltimore County, Baltimore, MD, USA.
Abstract: Hepatitis C Virus (HCV) is a major health concern; the virus infects
270-300 million people worldwide. The large number of people infected has
spurred efforts to identify small molecules that may be effective in treating
HCV infection. One of the targeted viral enzymes in these efforts is the viralRNA Dependent RNA polymerase (NS5B) that plays a vital role in replicat-
ing the HCV genome. Several allosteric inhibitors are known to bind to NS5B
in the thumb, fingers and palm domains of the enzyme. Our goal is to under-
stand the mechanism of allosteric inhibition in NS5B using molecular dy-
namic simulations. We are particularly interested in ligand AG6 that has
been shown to bind to the fingers domain. Relatively few allosteric inhibitors
are known to bind to this region of the protein. Studying allosteric inhibiton
involving this uncommon binding site has led to new insights into the mech-
anisms of allostery in NS5B. Moreover, crystallographic data indicate that
NS5B can bind simultaneously to AG6 and another allosteric inhibitor in
the thumb domain. This has given us an opportunity to learn what mecha-
nisms underlie synergistic binding of multiple allosteric inhibitors to the en-
zyme. We used molecular dynamic simulations to understand how changes in
the free energy landscape of NS5B mediate the allosteric effects of inhibitor
binding.
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We present the physicochemical basis of binding for several active peptides
from the compstatin family against the immune system protein C3. The pep-
tide sequences are tailored to promote enhancement of the structural and phys-
icochemical properties that contribute to binding, including consideration of
the dynamic character of the protein/ligand system. The peptide sequences
are designed using: (i) computational sequence selection and approximate
binding affinity calculations, (ii) molecular dynamics simulations, and (iii) ra-
tional optimization [1–3]. A subset of the new peptides has been tested in
ELISA inhibition assays using human serum, and produced comparable
IC50 values to those of known peptides. The most promising new designs ac-
quire an advantage in that they combine a more optimal balance between hy-
drophobicity, which is important for binding, and polarity, which is important
for solubility, compared to the most potent known peptides. Thus, the new
peptides are good candidates to become therapeutics, upon further optimiza-
tion. Given the species specificity of known compstatin family peptides for pri-
mate but not for non-primate mammals, some of the new designs aim at
binding to both human and rat C3. The dual specificity design was conducted
using molecular dynamics simulations based on our recent atomic detail model
for compstatin-human/rat binding [3]; however, the efficacy of the new pep-
tides for rat C3 binding and inhibition remains to be seen in experimental as-
says using rat serum.
[1] Bellows et al. 2010. New compstatin variants through two de novo protein
design frameworks, Biophysical Journal 98:2337–2346.
[2] Lo´pez de Victoria et al. 2011. A new generation of potent complement
inhibitors of the compstatin family, Chemical Biology & Drug Design
77:431–440.
[3] Tamamis et al. 2010. Species specificity of the complement inhibitor comp-
statin investigated by all-atom molecular dynamics simulations, Proteins
78:2655–2667.
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Intrinsically disordered proteins (IDPs) function in many important cellular
pathways, and their disruption contributes to many human diseases. IDPs dis-
play minimal if any secondary or tertiary structure in their unbound forms, but
will often fold into ordered structures upon binding. It is believed that the cou-
pling of folding and binding is important in balancing the affinity and specific-
ity of the interaction due to the reduction in conformational entropy of the
residues at the binding interface. Potential mechanisms include induced folding
and conformational selection, which are not mutually exclusive and the pre-
dominant method utilized may be biased by the entropic barrier in coupled fold-
ing and binding. A model system using the transactivation domain of the tumor
suppressor p53 (p53TAD) and its binding partners, the ubiquitin ligases MDM2
and its homologue MDMX, was designed. p53TAD is an IDP that folds when
binding with MDM2/X. The conformational entropy of p53TAD is systemati-
cally varied using mutagenesis and these mutations result in significant and pre-
dictable changes in the binding affinity. This is the first attempt to quantify how
